PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and BSL-3 facility, Fudan University, Shanghai, 200032, China.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and BSL-3 facility, Fudan University, Shanghai, 200032, China. lul@fudan.edu.cn.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and BSL-3 facility, Fudan University, Shanghai, 200032, China. zhyuan@shmu.edu.cn.\', \'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and BSL-3 facility, Fudan University, Shanghai, 200032, China. shibojiang@fudan.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41392-020-00402-5
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 33247109
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all